Zhibo Dang

436 total citations
12 papers, 312 citations indexed

About

Zhibo Dang is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Zhibo Dang has authored 12 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Hepatology and 3 papers in Oncology. Recurrent topics in Zhibo Dang's work include Liver Disease Diagnosis and Treatment (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease and Transplantation (2 papers). Zhibo Dang is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease and Transplantation (2 papers). Zhibo Dang collaborates with scholars based in China, South Korea and United States. Zhibo Dang's co-authors include Xinhui Wang, Yuyong Jiang, Xiaoli Liu, Xianbo Wang, Mengge Li, Lihua Yu, Zhiyun Yang, Yaxian Kong, Lingling He and Zhang Shuan and has published in prestigious journals such as Frontiers in Immunology, Phytomedicine and Cancer Immunology Immunotherapy.

In The Last Decade

Zhibo Dang

11 papers receiving 306 citations

Peers

Zhibo Dang
Li Liang China
Zhiqiu Hu China
Long Lv China
Zhibo Dang
Citations per year, relative to Zhibo Dang Zhibo Dang (= 1×) peers Zhiyun Yang

Countries citing papers authored by Zhibo Dang

Since Specialization
Citations

This map shows the geographic impact of Zhibo Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhibo Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhibo Dang more than expected).

Fields of papers citing papers by Zhibo Dang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhibo Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhibo Dang. The network helps show where Zhibo Dang may publish in the future.

Co-authorship network of co-authors of Zhibo Dang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhibo Dang. A scholar is included among the top collaborators of Zhibo Dang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhibo Dang. Zhibo Dang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Xie, Dong, et al.. (2025). Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances. Frontiers in Immunology. 16. 1581098–1581098. 2 indexed citations
2.
Liang, Yuling, Yuqing Xie, Zhibo Dang, et al.. (2024). Yiqi Liangxue Jiedu Prescription Inhibited the Canonical Wnt Pathway to Prevent Hepatocellular Precancerous Lesions. Journal of Hepatocellular Carcinoma. Volume 11. 2293–2308.
3.
Li, Mengge, et al.. (2023). A novel prognostic scoring system to predict portal vein tumor thrombosis in patients with hepatitis B virus-associated hepatocellular carcinoma.. PubMed. 15(7). 4600–4609. 2 indexed citations
4.
Li, Ling, et al.. (2021). Nek2B accelerates the progression of hepatocellular carcinoma through regulating SFRP1 to activate the Wnt/β-catenin pathway.. PubMed. 26(3). 861–867. 2 indexed citations
5.
Wang, Xinhui, Xiaoli Liu, Zhibo Dang, et al.. (2019). Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis. Gut and Liver. 14(2). 232–247. 32 indexed citations
6.
Liu, Xiaoli, Mengge Li, Xinhui Wang, et al.. (2019). PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma. Cancer Immunology Immunotherapy. 68(12). 2041–2054. 86 indexed citations
7.
Yu, Lihua, Xiaoli Liu, Xinhui Wang, et al.. (2019). Impact of gender as a prognostic factor in HBV-related Hepatocellular Carcinoma: the survival strength of female patients in BCLC stage 0-B. Journal of Cancer. 10(18). 4237–4244. 7 indexed citations
8.
Liu, Xiaoli, Mengge Li, Xinhui Wang, et al.. (2019). Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma. Phytomedicine. 62. 152930–152930. 149 indexed citations
11.
Shuan, Zhang, Lingling He, Xinhui Wang, et al.. (2018). A novel scoring model for predicting mortality risk in patients with cirrhosis and hepatorenal syndrome. European Journal of Gastroenterology & Hepatology. 30(8). 938–943. 5 indexed citations
12.
Liu, Xiaoli, Mengge Li, Xinhui Wang, et al.. (2018). Effect of serum triglyceride level on the prognosis of patients with hepatocellular carcinoma in the absence of cirrhosis. Lipids in Health and Disease. 17(1). 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026